Next-Generation Recombinant Factor IX Variant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Next-Generation Recombinant Factor IX Variant, covering 2021-08-09 to 2021-08-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B [Phase 2]